2017 Oregon Healthcare Policy Breakfast

On November 10th, the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society will host their annual Oregon Health Care Policy Breakfast, a premiere event that brings together leaders from the business, education, government and research communities. This year’s event will feature the complementary elements of cancer research and public policy advocacy in defeating cancer.

Government elected officials will be invited to participate to raise their awareness of the importance of state and federal cancer research funding in our state.  ACS CAN is committed to ensuring that our progress on critical policy issues continues by collaborating with key partners. We invite you to join us in the fight against cancer by attending the 2017 ACS CAN Oregon Healthcare Policy Forum.

Featured Speaker

Brian Druker, MD, is the director of the Knight Cancer Institute, associate dean for oncology of the OHSU School of Medicine, JELD-WEN Chair of Leukemia Research and a Howard Hughes Medical Institute investigator. His research is focused on translating the knowledge of the molecular pathogenesis of cancer into specific therapies and investigating the optimal use of these molecularly targeted agents. He performed preclinical studies that led to the development of imatinib (Gleevec) for chronic myelogenous leukemia and then spearheaded the highly successful clinical trials of imatinib, which led to FDA approval of the drug in record time and resulted in a paradigm-shift in cancer treatment from non-specific chemotherapy to highly targeted therapeutic agents.

ACS CAN Appreciates the Generous Support from Event Sponsors:

Amgen

Bristol-Myers Squibb

Johnson and Johnson

Novartis

OHSU Knight Cancer Institute

Pfizer